• 1
    Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 10630.
  • 2
    Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med 2004; 128: 76570.
  • 3
    Faycal J, Bessaguet C, Nousbaum JB et al. Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995. Gastroenterol Clin Biol 2005; 29: 2332.
  • 4
    Cunningham SC, Kamangar F, Kim MP et al. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg 2005; 9: 71825.
  • 5
    Tsubono Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer 2000; 3: 918.
  • 6
    Koizumi W, Narahara H, Hara T et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008; 9: 21521.
  • 7
    Ajani JA. Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen. Cancer 2008; 113: 94555.
  • 8
    Lee M, Vasioukhin V. Cell polarity and cancer-cell and tissue polarity as a non-canonical tumor suppressor. J Cell Sci 2008; 121: 114150.
  • 9
    Wodarz A, Nathke I. Cell polarity in development and cancer. Nat Cell Biol 2007; 9: 101624.
  • 10
    Tanos B, Rodriguez-Boulan E. The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene 2008; 27: 693957.
  • 11
    Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2012; 12: 2338.
  • 12
    McCaffrey LM, Macara IG. Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol 2011; 21: 72735.
  • 13
    Suzuki A, Ohno S. The PAR-aPKC system: lessons in polarity. J Cell Sci 2006; 119: 97987.
  • 14
    Ohno S. Intercellular junctions and cellular polarity: the PAR-aPKC complex, a conserved core cassette playing fundamental roles in cell polarity. Curr Opin Cell Biol 2001; 13: 6418.
  • 15
    Li Q, Wang JM, Liu C, Xiao BL, Lu JX, Zou SQ. Correlation of aPKCι and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2008; 7: 705.
  • 16
    Kojima Y, Akimoto K, Nagashima Y et al. The overexpression and altered localization of the atypical protein kinase Cλ/ι in breast cancer correlates with the pathologic type of these tumors. Hum Pathol 2008; 39: 82431.
  • 17
    Ishiguro H, Akimoto K, Nagashima Y et al. aPKCλ/ι promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6. Proc Natl Acad Sci USA 2009; 106: 1636974.
  • 18
    Regala RP, Weems C, Jamieson L et al. Atypical protein kinase Cι is an oncogene in human non-small cell lung cancer. Cancer Res 2005; 65: 890511.
  • 19
    Eder AM, Sui X, Rosen DG et al. Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci USA 2005; 102: 1251924.
  • 20
    Patel R, Win H, Desai S, Patel K, Matthews JA, Acevedo-Duncan M. Involvement of PKC-iota in glioma proliferation. Cell Prolif 2008; 41: 12235.
  • 21
    Takagawa R, Akimoto K, Ichikawa Y et al. High expression of atypical protein kinase C λ/ι in gastric cancer as a prognostic factor for recurrence. Ann Surg Oncol 2010; 17: 818.
  • 22
    Namdarian B, Wong E, Galea R et al. Loss of APKC expression independently predicts tumor recurrence in superficial bladder cancers. Urol Oncol 2011 (in press).
  • 23
    Chalmers AD, Pambos M, Mason J, Lang S, Wylie C, Papalopulu N. aPKC, Crumbs3 and Lgl2 control apicobasal polarity in early vertebrate development. Development 2005; 132: 97786.
  • 24
    Grifoni D, Garoia F, Bellosta P et al. aPKCζ cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia. Oncogene 2007; 26: 59605.
  • 25
    Suzuki A, Yamanaka T, Hirose T et al. Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J Cell Biol 2001; 152: 118396.
  • 26
    Buther K, Plaas C, Barnekow A, Kremerskothen J. KIBRA is a novel substrate for protein kinase Cζ. Biochem Biophys Res Commun 2004; 317: 7037.
  • 27
    Yoshihama Y, Hirai T, Ohtsuka T, Chida K. KIBRA co-localizes with protein kinase Mζ (PKMζ) in the mouse hippocampus. Biosci Biotechnol Biochem 2009; 73: 14751.
  • 28
    Yoshihama Y, Sasaki K, Horikoshi Y et al. KIBRA suppresses apical exocytosis through inhibition of aPKC kinase activity in epithelial cells. Curr Biol 2011; 21: 70511.
  • 29
    Yu J, Zheng Y, Dong J et al. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 2010; 18: 28899.
  • 30
    Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 2010; 18: 3008.
  • 31
    Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell 2010; 18: 30916.
  • 32
    Hill VK, Dunwell TL, Catchpoole D et al. Frequent epigenetic inactivation of KIBRA, an upstream member of the Salvador/Warts/Hippo (SWH) tumor suppressor network, is associated with specific genetic event in B-cell acute lymphocytic leukemia. Epigenetics 2011; 6: 32632.
  • 33
    Hamilton SR, Aaltonen LA. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARCP Press, 2000.
  • 34
    Sobin LH, Wittekind CH. TNM: Classification of Malignant Tumours, 6th edn. New York: John Wiley & Sons, 2002.
  • 35
    Sato K, Watanabe T, Wang S et al. Numb controls E-cadherin endocytosis through p120 catenin with aPKC. Mol Biol Cell 2011; 22: 310319.
  • 36
    Suzuki A, Hirata M, Kamimura K et al. aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity. Curr Biol 2004; 14: 142535.
  • 37
    Kang W, Tong JH, Chan AW et al. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res 2011; 17: 21309.